BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12739903)

  • 1. Cognitive rehabilitation with patients having persistent, severe psychiatric disabilities.
    Lewis L; Unkefer EP; O'Neal SK; Crith CJ; Fultz J
    Psychiatr Rehabil J; 2003; 26(4):325-31. PubMed ID: 12739903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-assisted cognitive rehabilitation reduces negative symptoms in the severely mentally ill.
    Bellucci DM; Glaberman K; Haslam N
    Schizophr Res; 2003 Feb; 59(2-3):225-32. PubMed ID: 12414079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation.
    Vauth R; Corrigan PW; Clauss M; Dietl M; Dreher-Rudolph M; Stieglitz RD; Vater R
    Schizophr Bull; 2005 Jan; 31(1):55-66. PubMed ID: 15888425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
    Minzenberg MJ; Poole JH; Benton C; Vinogradov S
    Am J Psychiatry; 2004 Jan; 161(1):116-24. PubMed ID: 14702259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia.
    Granholm E; McQuaid JR; Link PC; Fish S; Patterson T; Jeste DV
    Schizophr Res; 2008 Mar; 100(1-3):133-43. PubMed ID: 18222648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
    Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
    Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia.
    Velligan DI; Bow-Thomas CC; Huntzinger C; Ritch J; Ledbetter N; Prihoda TJ; Miller AL
    Am J Psychiatry; 2000 Aug; 157(8):1317-23. PubMed ID: 10910797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity.
    Gladsjo JA; McAdams LA; Palmer BW; Moore DJ; Jeste DV; Heaton RK
    Schizophr Bull; 2004; 30(4):739-54. PubMed ID: 15957196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia.
    Evans JD; Bond GR; Meyer PS; Kim HW; Lysaker PH; Gibson PJ; Tunis S
    Schizophr Res; 2004 Oct; 70(2-3):331-42. PubMed ID: 15329308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).
    Davidson M; Galderisi S; Weiser M; Werbeloff N; Fleischhacker WW; Keefe RS; Boter H; Keet IP; Prelipceanu D; Rybakowski JK; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Kahn RS
    Am J Psychiatry; 2009 Jun; 166(6):675-82. PubMed ID: 19369319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
    Purdon SE; Malla A; Labelle A; Lit W
    J Psychiatry Neurosci; 2001 Mar; 26(2):137-49. PubMed ID: 11291531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.
    Sharma T; Hughes C; Soni W; Kumari V
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):398-403. PubMed ID: 12845415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.